166 related articles for article (PubMed ID: 33058578)
21. New-onset psoriasis and psoriatic arthritis in a patient treated with Bacillus Calmette-Guérin (BCG) immunotherapy.
Dudelzak J; Curtis AR; Sheehan DJ; Lesher JL
J Drugs Dermatol; 2008 Jul; 7(7):684. PubMed ID: 18664162
[No Abstract] [Full Text] [Related]
22. Safety and Efficacy of Intravesical Bacillus Calmette-Guérin Immunotherapy in Patients with Non-Muscle-Invasive Bladder Cancer Presenting with Asymptomatic Bacteriuria: A Systematic Review.
Poletajew S; Zapała P; Radziszewski P
Urol Int; 2017; 99(1):1-5. PubMed ID: 28601885
[TBL] [Abstract][Full Text] [Related]
23. Fatal sepsis following intravesical bacillus Calmette-Guerin administration for bladder cancer.
Rawls WH; Lamm DL; Lowe BA; Crawford ED; Sarosdy MF; Montie JE; Grossman HB; Scardino PT
J Urol; 1990 Dec; 144(6):1328-30. PubMed ID: 2231917
[TBL] [Abstract][Full Text] [Related]
24. A Rare Case of Granulomatous Pneumonitis Due to Intravesical BCG for Bladder Cancer.
Clérigo V; Castro A; Mourato T; Gomes C
Acta Med Port; 2019 Apr; 32(4):316-320. PubMed ID: 31067427
[TBL] [Abstract][Full Text] [Related]
25. A systematic review of preventive and therapeutic options for symptoms of cystitis in patients with bladder cancer receiving intravesical bacillus Calmette-Guérin immunotherapy.
Poletajew S; Krajewski W; Adamowicz J; Radziszewski P
Anticancer Drugs; 2019 Jun; 30(5):517-522. PubMed ID: 30870228
[TBL] [Abstract][Full Text] [Related]
26. Complications of intravesical bacillus Calmette-Guerin: a case report.
Gonzalez JA; Marcol BR; Wolf MC
J Urol; 1992 Dec; 148(6):1892-3. PubMed ID: 1433632
[TBL] [Abstract][Full Text] [Related]
27. Polymyalgia rheumatica with temporal arteritis following intravesical Calmette-Guérin bacillus immunotherapy for bladder cancer.
Genereau T; Koeger AC; Chaïbi P; Bourgeois P
Clin Exp Rheumatol; 1996; 14(1):110. PubMed ID: 8697650
[No Abstract] [Full Text] [Related]
28. Bilateral orbital inflammation following intravesical bacille Calmette-Guérin immunotherapy for bladder cancer.
Takeuchi A; Taguchi M; Satoh Y; Ishida M; Takeuchi M
Jpn J Ophthalmol; 2012 Mar; 56(2):187-9. PubMed ID: 22350382
[No Abstract] [Full Text] [Related]
29. [BCG infection following intravesicular immunotherapy for bladder cancer].
Levi L; Groh M; De Castro N; Bergeron A; Schlemmer F
Rev Mal Respir; 2018 Apr; 35(4):416-429. PubMed ID: 29754838
[TBL] [Abstract][Full Text] [Related]
30. Nursing aspects of bacillus Calmette-Guerin immunotherapy for superficial bladder cancer.
LeBouton J
Urol Nurs; 1990 Dec; 10(4):9-14. PubMed ID: 2274796
[No Abstract] [Full Text] [Related]
31. Recombinant bacillus Calmette-Guérin in urothelial bladder cancer immunotherapy: current strategies.
Wang Y; Yang M; Yu Q; Yu L; Shao S; Wang X
Expert Rev Anticancer Ther; 2015 Jan; 15(1):85-93. PubMed ID: 25231670
[TBL] [Abstract][Full Text] [Related]
32. Difficulties in Diagnosing and Treating Disseminated Bacillus Calmette-Guérin (BCG) Infection After Intravesical BCG Therapy in a Patient with Liver Cirrhosis: A Case Report.
Vallilas C; Zachou M; Dolkiras P; Sakellariou S; Constantinou CA; Flevari P; Anastasopoulou A; Androutsakos T
Am J Case Rep; 2021 Oct; 22():e933006. PubMed ID: 34654796
[TBL] [Abstract][Full Text] [Related]
33. [Generalized BCG infection after intravesical instillations of Calmette-Guerin bacillus].
de Saint Martin L; Boiron C; Poveda JD; Herreman G
Presse Med; 1993 Oct; 22(29):1352-6. PubMed ID: 8248067
[TBL] [Abstract][Full Text] [Related]
34. Henoch Schönlein Purpura Nephritis Associated with Intravesical Bacillus Calmette-Guerin (BCG) Therapy.
Tsukada H; Miyakawa H
Intern Med; 2017; 56(5):541-544. PubMed ID: 28250302
[TBL] [Abstract][Full Text] [Related]
35. Hypersensitivity systemic reaction following intravesical bacillus Calmette-Guerin: successful treatment with steroids.
Molina JM; Rabian C; D'Agay MF; Modai J
J Urol; 1992 Mar; 147(3):695-7. PubMed ID: 1538462
[TBL] [Abstract][Full Text] [Related]
36. Aortic aneurysm and aortic graft infection related to Mycobacterium bovis after intravesical Bacille Calmette-Guérin therapy-a case series.
Buerger M; Kapahnke S; Omran S; Schomaker M; Rief M; Greiner A; Frese JP
BMC Surg; 2021 Mar; 21(1):138. PubMed ID: 33731071
[TBL] [Abstract][Full Text] [Related]
37. [Imaging findings in BCGitis--Bacillus-Calmette-Guérin-Infektion (BCGitis) after intravesical BCG instillation therapy in urothelial carcinoma of the urinary bladder].
Kaufmann S; Amend B; Kruck S; Gakis G; Bedke J; Horger M
Rofo; 2015 Aug; 187(8):623-7. PubMed ID: 26218471
[No Abstract] [Full Text] [Related]
38. Systemic bacillus-Calmette Guerin infection after transurethral administration for superficial bladder carcinoma.
Sakamoto GD; Burden J; Fisher D
J Urol; 1989 Oct; 142(4):1073-4; discussion 1074-5. PubMed ID: 2795734
[TBL] [Abstract][Full Text] [Related]
39. [Multiorgan failure following intravesical bacillus Calmette-Guerin administration: a case report].
Baba Y; Ishizu K; Jojima K; Joko K; Nakamura K; Takihara H; Naito K
Hinyokika Kiyo; 1992 Sep; 38(9):1063-5. PubMed ID: 1414761
[TBL] [Abstract][Full Text] [Related]
40. [Pulmonal bacillus Calmette-Guérin infection two years after intravesical bacillus Calmette-Guérin installation].
Harbjerg JL; Bjerre CC; Lillebæk T; Weinreich UM
Ugeskr Laeger; 2014 Dec; 176(25A):. PubMed ID: 25497624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
